LYNORIQInsightsStart free

What changed in Oscar Health, Inc.'s latest annual report

In the year ended 31 Dec 2025, Oscar Health, Inc.'s revenue rose 39% to USD 28.59m, from USD 20.58m; cash and cash equivalents rose 81.7% to USD 2.77bn, from USD 1.53bn; long-term debt rose 43.6% to USD 430.10m, from USD 299.56m.

Year ended 31 Dec 2025. Source: 10-K filed 13 Feb 2026, read it on SEC EDGAR.

USD 20.58m to USD 28.59m

Revenue, up 39% year on year

The figures, year on year

Annual figures as reported to the SEC, in US dollars. Changes are calculated from the two values.
ItemYear beforeLatest yearChange
Revenue20.58m28.59mUp 39%
Net income25.43m-443.15mNot comparable
Total assets4.84bn6.33bnUp 30.7%
Total liabilities3.82bn5.34bnUp 39.8%
Long-term debt299.56m430.10mUp 43.6%
Cash and cash equivalents1.53bn2.77bnUp 81.7%
Shareholders' equity1.01bn977.65mDown 3.5%

Questions people ask

Did Oscar Health, Inc.'s revenue grow last year?

Revenue grew 39%, from USD 20.58m to USD 28.59m in the year ended 31 Dec 2025.

Is Oscar Health, Inc. profitable?

Not in its latest year: it reported a net loss of USD 443.15m in the year ended 31 Dec 2025. The year before: USD 25.43m.

How much cash and debt does Oscar Health, Inc. have?

At its latest year end (31 Dec 2025), Oscar Health, Inc. reported cash and cash equivalents of USD 2.77bn and long-term debt of USD 430.10m.

Where do these numbers come from?

From Oscar Health, Inc.'s own annual filings with the SEC. Each change is calculated from the reported figures; nothing is estimated.

Meeting a client who works with Oscar Health, Inc.?

LYNORIQ remembers every client meeting the way this page tracks a filing: what changed since last time, what you promised, and what they owe you.

Start free See the demo

Other Hospital & Medical Service Plans companies

Oscar Health, Inc. (OSCR) 10-K: what changed year on year | LYNORIQ Insights